SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-270392
Filing Date
2019-10-21
Accepted
2019-10-21 06:57:17
Documents
14
Period of Report
2019-10-21
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d814533d8k.htm   iXBRL 8-K 26526
2 EX-99.1 d814533dex991.htm EX-99.1 22077
6 GRAPHIC g814533g1020082618919.jpg GRAPHIC 3560
  Complete submission text file 0001193125-19-270392.txt   181549

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA sgen-20191021.xsd EX-101.SCH 3092
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE sgen-20191021_lab.xml EX-101.LAB 17375
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sgen-20191021_pre.xml EX-101.PRE 10968
12 EXTRACTED XBRL INSTANCE DOCUMENT d814533d8k_htm.xml XML 3271
Mailing Address 21823 30TH DRIVE SE SUITE BOTHELL WA 98021
Business Address 21823 30TH DRIVE SE SUITE BOTHELL WA 98021 4255274000
SEATTLE GENETICS INC /WA (Filer) CIK: 0001060736 (see all company filings)

IRS No.: 911874389 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-32405 | Film No.: 191158728
SIC: 2836 Biological Products, (No Diagnostic Substances)